Sudden Infant Death Syndrome (SIDS) and Seratonin: The Genetic Segue

Professor Debra E. Weese-Mayer
Children’s Memorial Hospital, Chicago
£85,500 over 2 years

The aim of this research is to identify variations in genes that may contribute to the risk of SIDS. Identification of these genes may further define the genetic profile of infants at risk of SIDS; explain underlying mechanisms for SIDS; and ideally allow for the implementation of mechanism specific treatment of the “at risk” infant.